Is self-testing the next paradigm for diagnostics?

Area of Science:

• Medical Diagnostics
• Public Health
• Biotechnology

Background:

• India approved the CoviSelf™ AI-powered rapid antigen self-test kit for COVID-19 in April 2021.
• Self-testing kits offer a potential solution to diagnostic access limitations.
• Previous diagnostic methods often required specialized facilities and trained personnel.

Purpose of the Study:

• To assess the usability and user attitudes towards India's first approved rapid antigen self-test kit, CoviSelf™.
• To evaluate user comprehension of the test procedure and result interpretation.
• To determine if demographic factors influence the ease of use of the self-test kit.

Main Methods:

• A study was conducted to evaluate user interaction with the CoviSelf™ self-test kit.
• Participants' understanding, procedural performance, and result interpretation were assessed.
• Usability scores were analyzed across different age groups and genders.

Main Results:

• Over 90% of study participants correctly followed the instructions provided in the user manual.
• Usability scores were comparable across various age groups and genders, indicating consistent ease of use.
• The study demonstrated high user adherence to the self-testing protocol.

Conclusions:

• The CoviSelf™ rapid antigen self-test kit exhibits high usability among Indian users.
• This study supports the potential for a self-testing revolution, expanding diagnostic access for numerous diseases.
• Self-testing can overcome traditional barriers to healthcare access, similar to the internet's impact on information dissemination.